|
|
Metabolism
Other Agents Affecting Metabolism
|
|
|
|
BONEVELL
|
|
Indications
- Treatment of metastatic bone disease, to reduce the risk of skeletal complications of malignant disease including hypercalcemia, pain, the need for radiotherapy against painful bone lesions and impending fractures, and decrease the risk for fractures - Treatment of tumor-induced hypercalcemia
Pharmacology
Each 6 mL of Bonevell contains
Ibandronate Sodium 6.75 mg equivalent with Ibandronic Acid 6 mg
Package Quantities
Box 1 vial @ 6 ml
|
|
|
|
Ostovel
|
|
Indications
Postmenopausal
osteoporosis, Renal osteodystrophy in patients with chronic renal failure,
postsurgical hypoparathyroidism, idiophatic hypoparathyroidism,
pseudohypoparathyodism, Vitamin D-dependency rickets
Pharmacology
Each OSTOVEL softgel contains: Calcitriol ….………….……0.25 mg
Package Quantities
Bottle @ 30
softgels
|
|
|
|
Zolenic
|
|
Indications
Prevention of skeletal related events (pathological fractures, spinal compression, radiation or surgery to bone, or tumour-induced hypercalcaemia) in patients with advanced maglinancies involving bone. Treatment of Hypercalcaemia of Malignancy (HCM) "
Pharmacology
Each Zolenic contains Zoledronic Acid 4 mg
Package Quantities
Box of 5ml vial
|
|
|
|
|